期刊文献+

经典瞬时受体电位通道在高血压病发生发展中的作用及机制 被引量:1

原文传递
导出
摘要 经典瞬时受体电位通道(canonical transient receptor potential channels,TRPC)在很多疾病的发生发展中起到重要作用。近年来研究发现TRPC在高血压病的发生发展中起着重要作用,并与高血压的靶器官损害相关。大多认为TRPC介导钙离子内流引起平滑肌、内皮细胞增殖以及单核细胞激活等途径参与高血压发生发展的病理过程。
作者 罗偶 黄红光
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2014年第2期178-180,共3页 Chinese Journal of Cardiology
基金 湖南省自然科学基金(B2007173)
  • 相关文献

参考文献36

  • 1Abramowitz J,Birnbaumer L. Physiology and pathophysiology of canonical transient rec-eptor potential channels[J].Federation of American Societies for Experimental Biology,2009.297-328.
  • 2Schindl R,Frischauf I,Kahr H. The first ankyrin-likerepeat is the minimum indispensable key structure forfunctional assembly of homo and heteromeric TRPC4/TRPC5 channels[J].Cell Calcium,2008.260-269.
  • 3Inoue R,Jensen LJ,Shi J. Transient receptor potential channels in cardiovascular function and disease[J].Circulation Research,2006.119-131.
  • 4Eder P,Molkentin JD. TRPC channels as effectors of cardiac hypertrophy[J].Circulation Research,2011.265-272.
  • 5Pulina MV,Zulian A,Berra-Romani R. Upregulation of Na + and Ca2 + transporters in Arterial smooth muscle from ouaba-in-induced hypertensive rats[J].American Journal of Physiology-Heart and Circulatory Physiology,2010.H263-H274.
  • 6Shi J,Ju M,Abramowitz J. TRPC1 proteins confer PKC and phosphoinositol activation on native heteromeric TRPC1/C5 channels in vascular smooth muscle comparative study of wild-type and TRPC1-/-mice[J].Federation of American Societies for Experimental Biology,2012.409-419.
  • 7Takahashi K,Watanabe H,Murakami M. lnvolvement of transient receptor potential canonical 1 (TRPC1) in angiotensin Ⅱ induced vascular smooth muscle cell hypertrophy[J].Atherosclerosis,2007.287-296.
  • 8Shi J,Ju M,Saleh SN. TRPC6 channels stimulated by angiotensin Ⅱ are inhibited by TRPC1/C5 channel activity through a Ca2 +-and PKC-dependent mechanism in native myocytes[J].Journal of Physiology,2010,(Pt 19):3671-3682.
  • 9Liu D,Yang D,He H. Increased transient receptor potential canonical type 3 channels in vasculature from hypertensive rats[J].Hypertension,2009.70-76.
  • 10Koenig S,Schernthaner M,Maechler H. A TRPC3 blocker,ethyl-l-(4-(2,3,3-trichloroacry-lamide) phenyl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate (Pyr3),prevents stent-induced arterial remodeling[J].Journal of Pharmacology and Experimental Therapeutics,2013.33-40.

共引文献6

同被引文献10

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部